Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Treatment of childhood overweight and obesity.

BIBLIOGRAPHIC SOURCE(S)

  • Michigan Quality Improvement Consortium. Treatment of childhood overweight and obesity. Southfield (MI): Michigan Quality Improvement Consortium; 2008 Jun. 1 p.

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Michigan Quality Improvement Consortium. Treatment of childhood overweight. Southfield (MI): Michigan Quality Improvement Consortium; 2006 Nov. 1 p.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The level of evidence grades (A-D) are provided for the most significant recommendations and are defined at the end of the "Major Recommendations" field.

Children 2 Years or Older with a Body Mass Index (BMI) ≥ 85th Percentile

Identify Presence of Weight Related Risk Factors and Complications

Reinforce Prevention Recommendations (See also the National Guideline Clearinghouse [NGC] summary of the Michigan Quality Improvement Consortium [MQIC] guideline Prevention and Identification of Childhood Overweight)

History and Physical Exam [D]:

  • Family history, evaluate general co-morbidities including but not limited to cardiovascular disease and diabetes
  • History of medication use including nutritional supplements
  • Symptoms of gallbladder disease, Type 2 diabetes, obstructive sleep disorders, hypothyroidism
  • Presence of acanthosis nigricans
  • Weight-related orthopedic problems
  • Pulse and blood pressure, using appropriate technique and cuff size for age
  • Be alert to secondary causes of obesity. If aberrant findings are noted (short stature, hypotonia, hirsutism, etc.) then consider genetic and other endogenous causes of obesity.
  • Patient or parental concern about weight
  • Testing: Annual lipid profile and fasting glucose

Frequency

Each periodic health exam, more frequently as case requires.

Children 2 Years or Older with a BMI ≥ 85th – 94th Percentile (Overweight) without Risk Factors or Complications

Lifestyle Intervention to Reach Weight Maintenance

Consider All of the Above, Plus

Intervention to promote weight management/treatment [D]:

  • Reinforce lifestyle intervention and behavior modification. Focus is appropriate weight maintenance.
  • Family must be involved; small gradual changes are recommended towards the stated goal.
  • Monitor for increasing BMI percentile
  • Monitor for the development of risk factors or complications

Frequency

Consider management of childhood obesity as a medium- to long-term intervention.

Children 2 Years or Older with a BMI ≥ 85th – 94th Percentile with Risk Factors or Complications

Lifestyle Intervention with Treatment of Risk Factors and Complications as Needed

All of the Above, Plus

  • Primary goal of childhood weight interventions is regulation of body weight and fat with adequate nutrition for growth and development
  • Treat risk factors and complications as needed
  • Substantial slowing of weight gain may be achieved by relatively small but consistent changes in energy (200 to 500 kcal/day) intake, expenditure or both. If weight loss is desired, an appropriate starting goal is about 1 lb of weight loss per month.
  • Consider referral to multidisciplinary pediatric obesity treatment center, pediatric endocrinologist or registered dietitian

Frequency

Consider management of childhood obesity as a medium- to long-term intervention.

Children 2 Years or Older with a BMI ≥ 95th Percentile (Obese), with or without Risk Factors or Complications

Weight Loss with Concomitant Treatment of Risk Factors and Complications as Needed

All of the Above Plus

  • Long-term goal should be a body mass index below 85th percentile for age and sex
  • Consider aggressive approach to weight loss and treatment for patients after conservative approaches have failed
  • Consider aspartate transaminase (AST), alanine transaminase (ALT), blood urea nitrogen (BUN), and creatinine

Frequency

Consider management of childhood obesity as a medium- to long-term intervention.

Definitions:

Levels of Evidence for the Most Significant Recommendation

  1. Randomized controlled trials
  2. Controlled trials, no randomization
  3. Observational studies
  4. Opinion of expert panel

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Michigan Quality Improvement Consortium. Treatment of childhood overweight and obesity. Southfield (MI): Michigan Quality Improvement Consortium; 2008 Jun. 1 p.

ADAPTATION

DATE RELEASED

2006 Nov (revised 2008 Jun)

GUIDELINE DEVELOPER(S)

Michigan Quality Improvement Consortium - Professional Association

SOURCE(S) OF FUNDING

Michigan Quality Improvement Consortium

GUIDELINE COMMITTEE

Michigan Quality Improvement Consortium Medical Director's Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Physician representatives from participating Michigan Quality Improvement Consortium health plans, Michigan State Medical Society, Michigan Osteopathic Association, Michigan Association of Health Plans, Michigan Department of Community Health and Michigan Peer Review Organization

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Standard disclosure is requested from all individuals participating in the Michigan Quality Improvement Consortium (MQIC) guideline development process, including those parties who are solicited for guideline feedback (e.g., health plans, medical specialty societies). Additionally, members of the MQIC Medical Directors' Committee are asked to disclose all commercial relationships.

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Michigan Quality Improvement Consortium. Treatment of childhood overweight. Southfield (MI): Michigan Quality Improvement Consortium; 2006 Nov. 1 p.

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI Institute on July 13, 2007. The information was verified by the guideline developer on July 16, 2007. This NGC summary was updated by ECRI Institute on December 15, 2008. The updated information was verified by the guideline developer on December 17, 2008.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which may be reproduced with the citation developed by the Michigan Quality Improvement Consortium.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo